The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial effect in a patient; and techniques which can be used to obtain additional calcilytic compounds.
本发明涉及
钙受体拮抗剂化合物。"
钙受体拮抗剂化合物"指的是能够抑制
钙受体活性的化合物。还描述了利用
钙受体拮抗剂化合物来抑制
钙受体活性和/或在患者中达到有益效果的方法;以及可用于获取额外
钙受体拮抗剂化合物的技术。